Kalaris Therapeutics Reports Q3 Net Loss
(RTTNews) - Kalaris Therapeutics, Inc. (KLRS) on Tuesday, reported a lower net loss for the third quarter of 2026 compared with the same period in 2025, as operating expenses declined and other income remained positive.